CUNHA, Anthony; GAUBERT, Alexandra; LATXAGUE, Laurent; DEHAY, Benjamin

doi:10.3390/pharmaceutics13071042

Institut des Maladies Neurodégénératives [Bordeaux] [IMN]
Acides Nucléiques : Régulations Naturelle et Artificielle [ARNA]

GAUBERT, Alexandra

Acides Nucléiques : Régulations Naturelle et Artificielle [ARNA]

LATXAGUE, Laurent

Acides Nucléiques : Régulations Naturelle et Artificielle [ARNA]

Idioma

Article de revue

Este ítem está publicado en

Pharmaceutics. 2021-07-08, vol. 13, n° 7

Resumen en inglés

Treatment of neurodegenerative diseases has become one of the most challenging topics of the last decades due to their prevalence and increasing societal cost. The crucial point of the non-invasive therapeutic strategy for neurological disorder treatment relies on the drugs’ passage through the blood-brain barrier (BBB). Indeed, this biological barrier is involved in cerebral vascular homeostasis by its tight junctions, for example. One way to overcome this limit and deliver neuroprotective substances in the brain relies on nanotechnology-based approaches. Poly(lactic-co-glycolic acid) nanoparticles (PLGA NPs) are biocompatible, non-toxic, and provide many benefits, including improved drug solubility, protection against enzymatic digestion, increased targeting efficiency, and enhanced cellular internalization. This review will present an overview of the latest findings and advances in the PLGA NP-based approach for neuroprotective drug delivery in the case of neurodegenerative disease treatment (i.e., Alzheimer’s, Parkinson’s, Huntington’s diseases, Amyotrophic Lateral, and Multiple Sclerosis).< Leer menos

Palabras clave en inglés

PLGA nanoparticles

Neurodegenerative diseases

Drug delivery

Central nervous system

Neuroprotective drugs

URI

https://oskar-bordeaux.fr/handle/20.500.12278/148371

DOI

http://dx.doi.org/10.3390/pharmaceutics13071042

Ver/Abrir

Metadatos

Licencia de uso del documento

PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases

Idioma

Este ítem está publicado en

Resumen en inglés

Palabras clave en inglés

URI

DOI

Centros de investigación

Ver/Abrir

Metadatos

Compartir este ítem

Licencia de uso del documento

PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases

Idioma

Este ítem está publicado en

Resumen en inglés

Palabras clave en inglés

URI

DOI

Centros de investigación